The integration of acquisitions of high performing organizations continues to have less than ideal outcomes as you track those acquisitions a few years down range. One of the dynamics in nearly all acquisitions is the dilution of the culture, brand, and native mindset of the company that was so valuable, that is merited being acquired for a premium. The discussion of the recent Johnson & Johnson acquisitions of Shockwave and Abiomed is examined here.

Ver todos los episodios